Search Results | NIH

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2481 – 2500 of 3231

Table 5. Significant Drug Interactions for Drugs Used to Treat or Prevent Opportunistic Infections

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/table-5-significant-drug

Laboratory Testing: Plasma HIV-1 RNA (Viral Load) and CD4 Count Monitoring

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/plasma-hiv-1-rna-cd4-monitoring

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/overview

Long-Term Follow-Up of Infants Exposed to Antiretroviral Drugs

https://clinicalinfo.hiv.gov/guidelines/perinatal/management-infants-long-term-follow-up-exposed-arv-drugs

Financial Disclosure

https://clinicalinfo.hiv.gov/guidelines/perinatal/financial-disclosure

Protease Inhibitors

https://clinicalinfo.hiv.gov/guidelines/perinatal-hiv-clinical-guidelines/protease-inhibitors

Lopinavir/Ritonavir (Kaletra, LPV/r)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-protease-inhibitors-lopinavir-ritonavir-kaletra

Darunavir (Prezista, DRV)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-protease-inhibitors-darunavir-prezista

Initial Evaluation and Continued Monitoring of HIV During Pregnancy

https://clinicalinfo.hiv.gov/guidelines/perinatal/antepartum-care-initial-evaluation-monitoring-hiv-assessments-during-pregnancy

Appendix C: Antiretroviral Counseling Guide for Health Care Providers

https://clinicalinfo.hiv.gov/guidelines/perinatal/arv-counseling-guide

Hepatitis C Virus Infection

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/hepatitis-c-virus-infection

Intrapartum HIV Care

https://clinicalinfo.hiv.gov/guidelines/perinatal/intrapartum-care

Cobicistat (Tybost, COBI)

https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-pharmacoenhancers-cobicistat-tybost

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/ibalizumab

Insulin Resistance, Asymptomatic Hyperglycemia, Diabetes Mellitus

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/insulin-resistance-asymptomatic-hyperglycemia-diabetes-mellitus

https://clinicalinfo.hiv.gov/guidelines/perinatal/prepregnancy-counseling-care-overview

Integrase Inhibitors

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-arv/integrase-inhibitors

Pneumocystis Pneumonia

https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/pneumocycstis-jirovecii-pneumonia

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/efavirenz

Central Nervous System Toxicity

https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/cns-toxicity